Brought to you by:
Studies highlight need for tailored treatment options for women with peripheral arterial disease
New clinical results highlight the need for inclusive approaches and comprehensive examinations of treatment options for peripheral arterial disease (PAD), including endovascular therapy and revascularisation. The data were presented recently at the Society for Cardiovascular Angiography & Interventions (SCAI) 2024…
‘Who let a vascular surgeon in the room?’: Leadership in the face of turf battles in vascular disease treatment
Leading vascular surgeons from across the globe contributed pearls of wisdom on how to go about tackling inevitable turf battles from other specialties practicing in the vascular disease space during a leadership challenges session staged by the World Federation of…
Paclitaxel controversy: Yes, device restrictions did cause harm
“Unfortunately, we are doing worse for our patients today,” were the sobering thoughts of Eric Secemsky (Boston, United States) during a late-breaking presentation in this morning’s Peripheral Arterial Controversies programme. Among several presentations on paclitaxel safety, he reported that: yes,…
Study details link between increased functional status and improved survival in prosthesis-fitted amputees
Increasing functional status in vascular patients fitted with a prosthesis after amputation was incrementally associated with improved survival, a retrospective analysis of a 10-year experience at a Dallas-based practice showed. The team at Baylor Scott & White The Heart Hospital-Plano…
The top 10 most popular Vascular Specialist stories of March 2024
In March, the most read stories from Vascular Specialist include a new analysis which suggests of a ‘lack of reach’ of vascular voices within news coverage of vascular disease; a vascular surgery resident reflects on their experience of match day;…
FDA Breakthrough Device designation granted for DynamX BTK for use in CLTI treatment below the knee
Elixir Medical has announced Breakthrough Device designation by the Food and Drug Administration (FDA) for its novel DynamX BTK System, an implant for use in the treatment of narrowed or blocked vessels below-the-knee (BTK) in patients with chronic limb-threatening ischemia…
Bentley, Cook Medical enter US distribution agreement for BeBack device
Cook Medical and Bentley today announced a distribution agreement for the BeBack crossing catheter in the U.S., with Cook assuming commercial responsibilities for the Bentley product in the coming months. The BeBack device is designed for steering through chronic total…
Multi-society PAD Pulse Alliance aims to highlight importance of patient education
Society for Vascular Surgery (SVS) experts are spearheading initiatives as part of the multispecialty PAD Pulse Alliance and its Get a Pulse on PAD public awareness campaign aimed at educating and raising awareness of the risk factors and potential symptoms…
New analysis points to lack of vascular surgical voices in news coverage of vascular disease
A new study set to be aired at the 2024 Society for Clinical Vascular Surgery (SCVS) annual meeting (March 16–20) in Scottsdale, Arizona, sheds a statistical spotlight on the state of the specialty’s reach into the mainstream consciousness. A team…
IVUS use in claudicants not associated with improved outcomes, claims data show
The use of intravascular ultrasound (IVUS) for the treatment of claudication doubled over a four-year period but there was “no clear relationship between IVUS use and improved patient outcomes,” a recently presented retrospective analysis of claims data showed. Researchers found…